Wells Fargo Reiterates Overweight Rating on Amgen (AMGN)

April 17, 2024 12:30 PM EDT Send to a Friend
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $320.00 price target on Amgen (NASDAQ: AMGN). The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login